Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran.

Ramin RavangardFarideh Sadat JalaliMarjan HajahmadiAbdosaleh Jafari

Published in: Health economics review (2023)

According to the results, it is recommended that health policymakers consider the use of valsartan by cardiologists when designing clinical guidelines for the treatment of patients with heart failure.

Keyphrases

healthcare
public health
mental health
clinical practice
social media
climate change
replacement therapy
smoking cessation